Vol. 11, Issue 1 (2023)
Consequences, possible therapeutics and future directions for prevention & treatment of SARS-CoV2
Author(s): Pinki, Anita Phor and Ashu Chaudhary
Abstract: The major virus, SARS-CoV2 was spread from China in December 2019, and is accountable for the breathing manifestations that can prompt ARDS. The patients have created lethal difficulties in pregnancy, as observed in past coronavirus diseases. Some anti-rheumatic medications might be theorized to play the potential role for pathogenesis of COVID-19, successful immediate antiviral drugs, or directing on host immunity-based response. Antimalarial treatments, regularly utilized in rheumatic arthritis, could modify the cell organelle that intervenes the epidemiologic passage into the cell and have exhibited viability in refining the microbes. Rheumatic disorder patients consuming immunosuppressive medications ought to be prescribed to keep up the chronic therapy, forestall disease by staying away from social contacts, and stopping immunosuppressants if there should be an occurrence of infection. In this review article, we have indicated the side effects, transmission, implications, estimated therapeutics, and future bearings for the treatment of COVID-19.
Pages: 41-50 | 331 Views 76 Downloads
download (6870KB)
How to cite this article:
Pinki, Anita Phor, Ashu Chaudhary. Consequences, possible therapeutics and future directions for prevention & treatment of SARS-CoV2. Int J Chem Stud 2023;11(1):41-50.
